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Abstract
The current model of hepatitis C virus (HCV) production involves the assembly of virions on or near the surface of lipid
droplets, envelopment at the ER in association with components of VLDL synthesis, and egress via the secretory pathway.
However, the cellular requirements for and a mechanistic understanding of HCV secretion are incomplete at best. We
combined an RNA interference (RNAi) analysis of host factors for infectious HCV secretion with the development of live cell
imaging of HCV core trafficking to gain a detailed understanding of HCV egress. RNAi studies identified multiple
components of the secretory pathway, including ER to Golgi trafficking, lipid and protein kinases that regulate budding
from the trans-Golgi network (TGN), VAMP1 vesicles and adaptor proteins, and the recycling endosome. Our results support
a model wherein HCV is infectious upon envelopment at the ER and exits the cell via the secretory pathway. We next
constructed infectious HCV with a tetracysteine (TC) tag insertion in core (TC-core) to monitor the dynamics of HCV core
trafficking in association with its cellular cofactors. In order to isolate core protein movements associated with infectious
HCV secretion, only trafficking events that required the essential HCV assembly factor NS2 were quantified. TC-core traffics
to the cell periphery along microtubules and this movement can be inhibited by nocodazole. Sub-populations of TC-core
localize to the Golgi and co-traffic with components of the recycling endosome. Silencing of the recycling endosome
component Rab11a results in the accumulation of HCV core at the Golgi. The majority of dynamic core traffics in association
with apolipoprotein E (ApoE) and VAMP1 vesicles. This study identifies many new host cofactors of HCV egress, while
presenting dynamic studies of HCV core trafficking in infected cells.
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Introduction
Hepatitis C virus (HCV) is a member of the Flaviviridae family that
contains a single-stranded positive RNAgenome (,9600bp). This is
translated into a polyprotein, which is processed by viral and host
proteases into 3 structural proteins (core and the glycoproteins, E1
and E2) and 7 non-structural (NS) proteins (p7, NS2, NS3, NS4A,
NS4B, NS5A, NS5B). The discovery of HCV strains that are
infectious in cell culture has enhanced the appreciation of the
functions of these proteins in all stages of the viral life cycle [1–4].
Infectionofhepatocytesincell culture requiresatleastfourpotential
receptor molecules, CD81, SR-B1, claudins, and occludin [5–8].
Additionally, numerous entry cofactors involved in receptor-
mediated clathrin endocytosis are required [9–11]. Following
endosomal acidification, genomic RNA is released into the
cytoplasm where initial translation and replication occur. Replica-
tion is associated membranous structures derived from the
endoplasmic reticulum (ER) called the membranous web [12,13].
Following replication, genomic RNAs in complex with viral and
possibly cellular proteins are thought to transit to lipid droplets
(LD), where core protein localizes and virion assembly occurs [14–
18]. Although primary functions of the NS proteins include viral
RNA replication and host cell interactions, several NS proteins,
including p7, NS2, NS3, and NS5A are also implicated in HCV
assembly [19–27]. NS2 is a central regulator in capsid assembly
that appears to act as a scaffold to coordinate interactions between
the structural and non-structural proteins leading to viral RNA
encapsidation [19,22,23]. Capsid envelopment is thought to occur
at the ER, in close juxtaposition to LDs, based on the subcellular
localization of the E1 and E2 glycoproteins [28,29].
The events following HCV assembly are less clear. The egress of
flaviviruses through the secretory pathway is well documented and
may be similar to the mechanism by which HCV is secreted
[30,31]. However, HCV is distinct from the flaviviruses in that
HCV particles are infectious upon envelopment and appear to be
secreted from the cell in association with distinct lipid and
apolipoprotein associations [32–34]. HCV particles circulating in
the blood of infected patients are rich in triglycerides, apolipo-
protein B (ApoB), and apolipoprotein E (ApoE) [32,35–38]. The
low-density lipoprotein (LDL)-virus complex [39] possesses a
broad buoyant density, ranging between 1.03-1.25g/mL. Cell
culture-derived virus also has a broad range of buoyant densities,
with the lower density fractions containing virus highly infectious
virus [34,35,40]. Purified HCV virions have diverse morphologies
ranging from 30-125 nm and a lipid composition resembling very
low-density lipoprotein (VLDL) [34,40]. The VLDL synthesis
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interfering RNAs (siRNAs) or inhibitors that target components of
VLDL synthesis, including microsomal triglyceride transfer
protein, ApoB, and ApoE inhibit infectious HCV secretion
[32,33,35,36,41,42].
This study is a continuation of two previous RNAi studies in
which membrane trafficking pathways were interrogated for their
roles in HCV entry and replication [43,44]. In this study, we
identified numerous host cofactors that are required for infectious
HCV secretion, but not HCV entry or replication. We next
developed a live cell imaging approach to study HCV core
trafficking using an infectious HCV that contains a tetracysteine
(TC) tag insertion in the core protein (TC-core). This approach
has been successfully used before to visualize single virion HIV-1
budding [45–47] and vesicular stomatitis virus (VSV) endocytosis
[48,49] without major defects in virus infectivity. TC-core
movements that are dependent upon successful virion assembly
were microtubule-dependent and associated with several compo-
nents of the secretory pathway that were identified in the RNAi
analysis.
Results
Host genes involved in HCV secretion
This study is a part of a larger analysis, which interrogated a
previously described unique siRNA library that targeted known
membrane trafficking pathways [43,44]. The library consisted of
122 siRNAs targeted to membrane trafficking genes from
Dharmacon, Inc and was supplemented with 18 additional genes
important for replication and membrane organization in other
viral systems [44]. We first identified siRNAs that inhibited
infectious extracellular HCV accumulation in a primary screen
and then re-tested these siRNAs in secondary assays to identify the
stage of the life cycle that they influenced. Genes involved in entry
had a secondary phenotype in inhibiting HCV pseudoparticle
(HCVpp) infection [43] and genes involved in HCV replication
had a defect in subgenomic replicon replication [44].
The primary screen was performed by electroporating four
individual siRNAs per gene into Huh-7.5 cells and then allowing
silencing for 48 or 72 hours before infection with HCV. Viral
supernatants were collected at two days post infection (dpi) and
viral titers were quantified via limiting dilution in at least two
independent experiments, measured in duplicate, and normalized
to at least 4 replicates of cells silenced with an irrelevant siRNA
(siIRR) (Table 1). The siRNAs that inhibited extracellular
infectious HCV production by more than 1 standard deviation
of siIRR treated cells (.65% inhibition) were classified as ‘‘hits’’
and were characterized in secondary assays. To limit the possibility
of siRNA off-target effects, individual siRNAs then were tested.
We quantified cell viability using a luminescence-based assay that
measures cellular ATP levels, following 5 days of silencing to
eliminate phenotypes resulting from significantly decreased
viability (p,0.001) (Figure S1).
In this study, genes that were required for infectious HCV
production, but not HCVpp entry or replicon replication, were
further tested for a role in infectious HCV secretion. We repeated
the RNAi analysis and quantified intra- and extra-cellular HCV
infectivity following HCV infection of siRNA-treated cells. Table 1
shows the ratio of intra- to extra-cellular virus, with a value greater
than 1 indicating a defect in extracellular infectious HCV release.
The titer of intracellular virus did not decrease significantly in
these siRNA treatments as compared to siIRR (Figure S2),
indicating the genes (Table 1) are not involved in HCV assembly,
but rather the secretion of infectious particles.
The siRNA screen identified multiple components of the
secretory pathway, from ER to Golgi trafficking (SAR1A), to
Golgi structure and function (CYTH3), cargo sorting and vesicle
budding from TGN (PRKD1, AP1M1, PI4KB, CLINT1),
regulators of TGN to plasma membrane trafficking (RAB11A,
RAB3D, PACSIN3), and the v-snare, VAMP1. This suggests that
HCV virions egress through the secretory pathway from the TGN
to recycling endosomes to the plasma membrane. A role for ER to
Golgi trafficking genes, such as SAR1A, ARF3, and CYTH3, in
the egress of infectious HCV is supported by previous data
showing that brefeldin A treatment of infected cells accumulates
intracellular infectious HCV [35]. Additional genes cluster into
actin and membrane remodeling pathways (RHOA, GIT1, WAS).
Table 1. siRNAs perturbing infectious HCV secretion.
Percent Inhibition*
Gene
Infectious
HCV
Host Gene
RNA
Intra-:Extra-
cellular virus Function
SAR1A 80 64 4.10 ER -. Golgi
CYTH3 87 75 3.35 Golgi function
CLINT1 77 70 2.99 Golgi sorting
PI4KB 90 76 13.73 Golgi sorting
PRKD1 73 75 3.43 Golgi sorting
AP1M1 85 81 2.32 Golgi Sorting
PACSIN3 76 91 2.71 Vesicle trafficking
ARF3 75 73 2.18 Golgi trafficking
RAB11A 82 61 3.51 Exocytosis
RAB3D 69 80 9.94 Exocytosis
VAMP1 81 77 5.04 Exocytosis
RHOA 75 71 2.65 Actin/remodeling
GIT1 71 69 3.04 Actin/remodeling
WAS 71 91 5.87 Actin/remodeling
*as compared to siIRRelevant treated cells.
doi:10.1371/journal.ppat.1002466.t001
Author Summary
The current model of HCV egress is that virions assemble
at lipid droplets, envelope at the ER and then likely exit the
hepatocyte via the secretory pathway in association with
apolipoproteins. To gain a more detailed insight into
infectious HCV release, we combined an RNAi analysis of
host factors that are required for infectious HCV secretion
with live cell imaging of HCV core trafficking. Using this
approach, we identified numerous components of the
secretory pathway that are both required for infectious
HCV release and co-traffic with HCV core. The dynamics of
HCV core trafficking, both in terms of frequency of
transport, particle velocity, and the corresponding run
lengths were quantified. We observe that dynamic core
movements in the periphery require NS2, a viral protein
required for virion assembly. Core co-traffics with multiple
components of the secretory pathway, including the Golgi,
recycling endosome, microtubules, VAMP1 secretory
vesicles, and ApoE. This study identifies new molecular
determinants of HCV secretion and describes the dynamics
of their movements with HCV core in real time.
HCV Secretion Pathway
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labeled HCV core
To study the dynamics of HCV core trafficking in Huh-7.5 cells,
a TC tag was fused in frame following amino acid three of the
structural protein core in a derivative of J6/JFH-1, a chimeric
genotype 2a isolate. The TC sequence of CCPGCC can
coordinate biarsenical dyes, FlAsH and ReAsH. The TC-core
virus replicates comparably to wild type (Figure 1A), with a mild
impairment of infectious virus production (Figure 1B). ReAsH
treatment of TC-core infected cells does not impair infectious virus
production (Figure S3).
We first tested the specificity of labeling by examining whether
FlAsH TC-core fluorescence overlapped with core detected by
standard immunofluorescence. TC-core RNA was electroporated
into Huh-7.5 cells and three days later the cells were treated with
FlAsH biarsenical dye, then processed for immunofluorescence
using a monoclonal antibody against HCV core (Figure 2A). Both
antibody and FlAsH dye detected the same punctate structures
located in the cytoplasm of infected cells and were not present in
uninfected cells. Quantitation of FlAsH and anti-core puncta
determined that 86.5% of the TC-core FlAsH signal overlapped
with the core antibody fluorescence (Figure 2B), demonstrating
specificity of the FlAsH staining.
The localization of HCV E2 relative to TC-core was analyzed
by probing for TC-core with FlAsH dye and processing for
immunofluorescence with a monoclonal antibody against E2
(Figure 2A). E2 expressed from the TC-core virus had the
expected reticular pattern and was also found on a subset of
cytoplasmic core puncta (Figure 2A) when we used an E2 antibody
that detects E2 on assembled viral particles [3,50], 21.8% of the
TC-core signal overlapped with that of E2 fluorescence
(Figure 2B). Some TC-core structures that were positive for E2
were found in the cell periphery, suggesting they may represent
intracellular assembled viral particles. We then investigated
whether we can visualize core and RNA, as would be expected
for bona fide HCV virions. RNA localization was examined in wild
type infected cells using ‘‘Click-iT’’ technology (Invitrogen) and
cells were stained using an anti-core antibody (Figure 2B). We
observe that 20.1% percent of anti-core colocalizes with RNA.
Thus, sub-populations of core are associated with E2 and RNA,
although we cannot conclude whether the observed RNA
represents HCV genomes.
Next, we imaged TC-core movement in living cells. Huh-7.5
cells were electroporated with TC-core RNA, maintained for
72 hours, and stained with ReAsH dye followed by imaging using
confocal microscopy. We chose to image at 72 hours post
electroporation because TC-core was highly expressed and
detectable by biarsenical dye staining and antibody detection
(Figure 2A), maximal amount of virus was released as assessed by
viral titer assay (Figure 1B), and HCV induced lipid droplet
relocalization to the microtubule organizing center should have
occurred indicating assembly of particles was initiated [15].
Several TC-core particles are detectable in a whole cell image
(Figure 2C) and a sub-population of particles displayed various
movements at 72 hours post electroporation. The movements
were either roughly static (Figure 2C particle 1), saltatory with
many reversals in direction (Figure 2C particles 2–4), or
directional movement (Figure 2C particle 5, Video S1). We then
stained TC-core expressing cells with a RNA selective dye,
Ribogreen, processed for ReAsH visualization of TC-core and
then imaged in live cells. We observe co-trafficking of TC-core
with the RNA dye, indicating that dynamic TC-core puncta
associate with RNA (Figure 2D, Video S12).
NS2 is required for dynamic TC-core movements
We next tested whether the sub-population of dynamic TC-core
movements require productive HCV virion assembly. As discussed
earlier, multiple groups have published that HCV nonstructural
(NS) protein 2, NS2, is required for HCV assembly by acting as a
scaffold bridging structural and non-structural proteins
[19,22,23,51]. The function of NS2 in assembly does not require
its juxtaposition next to NS3 in the viral genome, such that HCV
RNAs with an encephalomyocarditis virus (EMCV) internal
ribosome entry site (IRES) inserted between NS2 and NS3 are
infectious [52]. Therefore, we constructed two additional viruses, a
bicistronic HCV with the TC-core tag and a bicistronic TC-core
version with a deleted NS2 (DNS2) (Figure 3A). RNAs were
transcribed in vitro and electroporated into Huh-7.5 cells, then
RNA replication and intra- and extra-cellular infectious virus were
quantified over a time course. As expected, both bicistronic
constructs were replication competent, (Figure 3B), while only the
bicistronic virus containing NS2 was capable of producing
infectious virus (Figure 3C).
HCV capsid assembly is dependent on the association of core
with the lipid droplet [15]. To examine the association of TC-core
Figure 1. Characterization of tetracysteine (TC) tag insertion in core. A. Replication data for WT (J6/JFH1) and TC-core viruses. Time points
indicated. Error bar, standard deviation. B. Titer data for WT and TC-core viruses. Viral supernatants were collected at indicated timepoints and titered
by limiting dilution assay. Shown are the averages of 4 sets of titer data. Error bar, standard deviation.
doi:10.1371/journal.ppat.1002466.g001
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PLoS Pathogens | www.plospathogens.org 3 January 2012 | Volume 8 | Issue 1 | e1002466Figure 2. Characterization of TC-core puncta. A. Huh-7.5 cells were electroporated with TC-core RNA. At 72 hours post electroporation (hpe),
cells were stained with FlAsH (1.25 mM, green) then fixed and stained for immunofluorescence using anti-core or anti-E2 antibodies (red). Scale bar is
10 microns. Fluorescence profiles of lined area in A. Distance is in pixels and intensity is in arbitrary fluorescence units (AFU). Percent colocalization of
FlAsH stained puncta positive for anti-core or anti-E2 per cell is shown is upper left corner of fluorescence profile. B. Huh-7.5 cells were infected with
HCV for 72 hours, treated with Click-iT in the presence of actinomycin D (1 mg/mL) to detect RNA, fixed, and probed with core antibody. C. Left: Single
frame of an acquired fluorescent timelapse where DsRed exposures were taken every 2 seconds. Right: Single frame image where 5 particles were
tracked and the trajectories are superimposed. Elapsed time between images is 100 seconds. Video S1. Scale bar is 10 mm. D. TC-core RNAs were
HCV Secretion Pathway
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ed into Huh-7.5 cells followed by staining with ReAsH dye and the
neutral lipid stain (Bodipy 493/503) to detect lipid droplets prior
to imaging. All constructs displayed core accumulation in large
concentric rings or crescents around larger lipid droplets (Figure 4),
indicating that TC-core had appropriate lipid droplet association.
We next examined whether the dynamic TC-core movements
observed previously (Figure 2C) required HCV virion assembly.
Timelapse fluorescence microscopy of individual TC-core puncta
was performed 72 hours post electroporation with TC-core,
bicistronic or DNS2 RNAs. Individual TC-core puncta (of which
we can detect using an core antibody) were visualized by live cell
confocal microscopy by capturing DsRed exposures every 2
seconds for several minutes (Videos S2–4). Biarsenical dye signal
photobleached quickly, therefore timelapse acquisition was limited
to short exposures over several minutes (usually up to 10 minutes).
A sub-population of cytoplasmic TC-core puncta in cells
electroporated with either TC-core or bicistronic RNAs displayed
directional movements, whereas DNS2 TC-core puncta were static
(Figure 5A) or displayed random movements. The TC-core puncta
that displayed movements greater than 1 mm as a percentage of
total core puncta in a cell was similar between the TC-core and
bicistronic populations; 18.2%61.22, n=1010 at 72 hours post
electroporation (hpe) for TC-core RNAs and 17.2%61.6, n=558,
for bicistronic RNAs (Figure 5B). In contrast, the frequency of TC-
core puncta expressed from the DNS2 virus that exhibit directed
movement (greater than 1 mm) was virtually nonexistent,
0.65%61.9, n=617 (Figure 5B). Extended imaging of the DNS2
TC-core virus at 96 and 120 hours post electroporation did not
show an increase in TC-core puncta movement (data not shown)
indicating cytoplasmic movements of TC-core were dependent on
NS2 function independent of viral kinetics.
The dynamics of TC-core trafficking were examined by
distance from origin analysis. The cumulative distance traveled
(in any direction) by a TC-core puncta during an imaging session
was measured and plotted for each virus from a single particle.
The distance from origin plots show core puncta in TC-core and
bicistronic expressing cells had extensive total movements
ranging from 3-17 microns per minute from the point of origin
during an imaging session (Figure 5C). Core puncta expressed
from the DNS2 virus displayed restricted movements ranging
from 0-5 microns from the point of origin during imaging
(Figure 5A,C), suggesting long range movements occur post
assembly.
Figure 3. Construction and characterization of assembly mutants in TC-core background. A. Drawing indicating insertion site of TC-tag
into core after amino acid 3. Shown are the TC-core, bicistronic, and NS2 deletion (DNS2) viruses. B. Replication data for TC-core, bicistronic, and DNS2
viruses. Time points indicated. Error bar, standard deviation. C. Intra- and extra-cellular infectious virus production for TC-core, bicistronic, and DNS2
RNAs. Virus was collected at indicated timepoints and titered by limiting dilution assay. Dotted line indicates detection limit for titer assay. nd, not
detectable. Error bar, standard deviation.
doi:10.1371/journal.ppat.1002466.g003
electroporated into Huh-7.5 cells, maintained for 72 hours, stained with ReAsh (red) and Ribogreen (1 ml/ml), and visualized by live cell fluorescence
microscopy. A representative montage of TC-core puncta transporting with RNA is shown. Elapsed time is 1 minute and 50 seconds seconds and the
distance traveled is approximately 8.32 mm. Video S12.
doi:10.1371/journal.ppat.1002466.g002
HCV Secretion Pathway
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single particles were quantified by manual tracking. A run was
defined as a period of uninterrupted transport lacking a pause. A
pause was defined as a stop in motion greater than one frame, in
this case 2 seconds between image acquisitions. TC-core puncta
displayed saltatory (stop and start) movements with few processive
runs and reversals where particles switched direction. The average
run length displacement of wild type TC-core moving puncta was
2.457 mm 6 .1215 (mean 6 SEM, n=154, Figure 6B) and fit a
decaying exponential, R
2=.9924, which is consistent with
microtubule associated transport. The average velocity of moving
TC-core puncta was .1336 mm/second 6 .010139 (mean 6 SEM,
n=154, Figure 6A) and could be modeled by a Gaussian
distribution, R
2=.9983. The TC-core dynamics of run length
and the velocity are consistent with secretory vesicle trafficking
(Figure S13) [53,54].
TC-core moves in association with microtubules
HCV core mediates redistribution of lipid droplets to the
microtubule-organizing center (MTOC) by microtubule directed
transport [55]. The dynamics of peripheral TC-core movements
are also suggestive of microtubule-dependent transport. To
determine if TC-core puncta were associated with microtubules
during transport, TC-core electroporated cells were stained with
ReAsH at 72hpe and microtubules were visualized with
TubulinTracker Green (Invitrogen). Figure 7A (Video S5) shows
TC-core puncta movement associated with a microtubule (top).
We next tested whether microtubule disruption with nocodazole
treatment perturbs TC-core trafficking (Figure 7A-C, Videos S5
and S6). TC-core expressing cells were incubated with nocodazole,
DMSO, or left untreated then TC-core puncta dynamics were
recorded by timelapse imaging. The run lengths displayed by
single particles were determined by manual tracking and the
displacement between frames (distance) was plotted against time
(Figure 7B). Both the untreated and DMSO treated cells showed
similar core dynamics, in which core particles were static,
randomly moving, or processively moving. Alternatively, nocoda-
zole treatment dramatically decreased TC-core puncta dynamics
(Figure 7A-C), where the majority of particles displayed static or
random movements that did not result in long distance
displacements.
TC-core traffics with components of the secretory
pathway
We next validated the results of our RNAi analysis by
examining the localization and trafficking of TC-core with cellular
cofactors that were identified in the screen. A number of the
cellular cofactors are involved in Golgi function and sorting at the
TGN, including, CYTH3, PI4KB, PRKD1, and AP1M1. We first
examined whether TC-core colocalizes with Golgi markers.
Figure 4. TC-core localizes to lipid droplets. Huh-7.5 cells electroporated with TC-core, bicistronic, or DNS2 RNAs were stained with ReAsH dye
(red) at 72 hours post electroporation and incubated with Bodipy-493/503 (green) to label lipid droplets. Scale bar is 10 microns.
doi:10.1371/journal.ppat.1002466.g004
HCV Secretion Pathway
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examined for localization with the Golgi markers Golgi-GFP
(Invitrogen, Golgi and Golgi stacks) or GM130 (cis- face of the
Golgi) (Figure 8). We observe that a sub-population of TC-core
colocalizes with the Golgi. The overall frequency of colocalization
is relatively low, as would be expected for a transient association of
core with the Golgi.
The role of exit from the Golgi in TC-core trafficking was
assessed by quantifying the effects on TC-core movements in the
presence of inhibitors of two genes identified in the RNAi screen:
brefeldin A (BFA), which inhibits ARF3, and PIK93, which
inhibits PI4KB. BFA treatment inhibits secretion of viral particles
[35]. PI4KB is a resident Golgi lipid kinase that is important in
trafficking from the Golgi to the plasma membrane. PIK93 is a
selective inhibitor of the type III PI4 kinase, PIK4B, at the
concentration used in this experiment (.5 mM) [56,57]. Treatment
with BFA or PIK93 significantly reduced the average velocity of
motile TC-core puncta (Figure 8B), further supporting a role of the
secretory pathway in HCV secretion.
We next examined the trafficking of TC-core with ApoE, a
component of VLDL secretion [58]. ApoE is required for HCV
infection and is associated with extracellular infectious HCV
virions [32–34,59,60]. The association of HCV and lipoproteins is
thought to occur early during assembly, then HCV is secreted as a
lipo-viroparticle [28,33,34,36,59,61–63]. In normal hepatocytes,
ApoE exits the cell by using the secretory pathway and can also
transit through the recycling endosomal pathway [58,64–66].
ApoE is also associated with VLDL particles during secretion [58]
and with secretory vesicles leaving the Golgi [66] where VLDL
particles mature [67]. We constructed a C-terminal GFP fusion to
ApoE, ApoE-GFP, to determine if TC-core puncta traffic with
ApoE in live cells. ApoE-GFP had a cytoplasmic localization that
could be detected with an ApoE antibody (Figure S4). TC-core
expressing cells were transfected with ApoE-GFP at 48hpi
followed by live cell imaging at 72hpi. Dynamic TC-core puncta
(from transfected and infected cells) were found to colocalize with
ApoE-GFP (Figure 9a, Figures S5 & S11, Videos S7 & S13) in the
cell periphery. This observation suggests that ApoE is associated
with de novo forming HCV particles during secretion instead of
being acquired extracellularly. We determined the percentage of
TC-core puncta moving with ApoE-GFP to be 81.25%68.98,
n=26/32 of moving TC-core puncta. We also investigated
colocalization of core with ApoB. Although some colocalization
of core and ApoB was observed in the proximity of lipid droplets,
little colocalization between core and ApoB occurred in the
periphery (Figure S6).
A gene identified in the RNAi screen to be required for
extracellular release of infectious HCV was Rab11A, a small GTP
binding protein. Rab11A modulates transport through the
recycling endosome [68], associates with apical targeting in
Figure 5. Dynamic TC-core movements require HCV assembly. Huh-7.5 cells were electroporated with TC-core, bicistronic, or DNS2 RNAs.
Electroporated cells were stained at 72 hours post electroporation with the biarsenical dye ReAsH and imaged using timelapse confocal microscopy
where DsRed (200 ms) exposures were taken every 2 seconds. A. Timelapse montages of TC-core puncta transport of the viruses imaged. Time on x-
axis. Elapsed times are 40sec (TC-core), 40sec (bicistronic), 132sec (DNS2) and height (distance traveled) of each montage is 12.48 mmB .
Quantification of percent of TC-core puncta displaying movement over 1 mm during the course of imaging. Values are shown as a percentage of total
cellular TC-core puncta. n-values equal total number of TC-core puncta, error bars are standard error (of the proportions). Asterisk indicates p-value
,0.0001. C. Distance from origin plots of TC-core viruses. The cumulative distance traveled by a TC-core puncta was measured and plotted against
time. n-values indicate total TC-core puncta tracked.
doi:10.1371/journal.ppat.1002466.g005
HCV Secretion Pathway
PLoS Pathogens | www.plospathogens.org 7 January 2012 | Volume 8 | Issue 1 | e1002466polarized cells [69], and is involved in transporting cargoes from
the Golgi to the plasma membrane [70]. Rab11 is required for
budding of influenza virus [71], hantavirus release [72], and
involved in the vesicular trafficking of Sendai virus ribonucleo-
capsids [73]. We constructed a N-terminal GFP fusion to Rab11A,
and imaged TC-core and Rab11A cotrafficking by timelapse
fluorescence microscopy (Figure 9B, Figures S4 & S7, Videos S8
and S14). GFP-Rab11a had a cytoplasmic localization that was
either associated with the Golgi network or alone in puncta (Figure
S4). We also visualized TC-core with a second marker of the
recycling endosome, transferrin. TC-core electroporated Huh-7.5
cells were incubated with Alexa Fluor 488 conjugated transferrin,
and cotrafficking of TC-core and transferrin was imaged using live
cell microscopy (Figure 9C, Figure S8, Video S9). We determined
the percentage of moving TC-core puncta associated with Rab11a
and transferrin 488 markers to be 61.2%68.7% (n=19/31 of
moving TC-core puncta) and 50.0%65.3% (n=44/88 of moving
TC-core puncta), respectively. The cotrafficking of TC-core with
markers of the recycling endosome validates the RNAi data that
implicates a role for the recycling endosome in infectious HCV
secretion.
Although the cotrafficking of TC-core with various cellular
markers was initially done in cells electroporated with TC-core
HCV RNAs, we subsequently confirmed co-trafficking the results
following infection with TC-core virus (Figure S11). We next
tested whether the defects in infectious HCV production following
Rab11a silencing were associated with altered core trafficking.
Huh-7.5 cells were electroporated with Rab11a siRNAs, main-
tained for two days, infected with HCV for two days, fixed and
probed with antibodies to core and the Golgi marker GM130. We
observe an increase in core accumulation at the Golgi following
Rab11a silencing (Figure 10A,C, 30.265.5% (n=1350)) of Golgi
stacks are core positive in siIRR treated cells versus 55.767.4%
(n=1517) in siRab11a treated cells. Thus, the defect in infectious
HCV release in siRab11a treated cells correlates with an
accumulation of core in the Golgi network.
Vesicular associated membrane 1 (VAMP1) was identified as a
cofactor in the release of extracellular infectious HCV in our
RNAi screen. VAMP1 can complex with syntaxins and SNAP25
to form a SNARE complex involved in docking and/or fusion of
vesicles at the plasma membrane [74]. We constructed a N-
terminal GFP fusion to VAMP1 and visualized cotransport of
GFP-VAMP1 and TC-core (Figure 9D, Figure S9, Video S10 and
S15). GFP-VAMP1 localized to puncta in the cytoplasm and could
be detected using an anti-VAMP1 antibody (Figure S4). We found
a high percentage of TC-core puncta (79.4% 6 8.90 n=135/170
of moving TC-core puncta) co-trafficking with GFP-VAMP1 in
the cell periphery suggesting that TC-core is transported in
VAMP1 associated vesicles. It is well established that the secretory
and endosomal pathways intersect to deliver vesicular cargoes to
the plasma membrane. To determine if TC-core puncta
transported in the lumen of a vesicle, we incubated TC-core
electroporated cells with dextran and found that the dynamic TC-
core trafficked with dextran (Figure 9E, Figure S10, Supplemental
Video S11) with a frequency of 82.5%6 6.0% (n=33/40 moving
TC-core puncta). This evidence further supports that core is
vesicle-associated during secretion.
Finally, we tested whether silencing the Golgi lipid kinase
PI4KB would decrease the association of core with VAMP1.
siRNA treated cells were transfected with GFP-VAMP1, infected
with wild type HCV for two days and processed for core and GFP-
VAMP1 imaging. We observed extensive colocalization of core
and GFP-VAMP1 (65.162.5% (n=366)) in siIRR treated cells
(Figure 10B and D). However in cells treated with siPIK4B, fewer
core and GFP-VAMP1 colocalization (19.262.3% (n=286)) was
observed (Figure 10B and D). Thus, PI4KB expression is required
for core colocalization with VAMP1.
Discussion
This study combined a RNAi analysis to identify host genes
involved in the release of infectious HCV from cells with live cell
Figure 6. TC-core transport kinetics. Huh7.5 cells were electropo-
rated with TC-core RNA and stained with ReAsH dye at 72 hours post
electroporation. Infected cells were imaged by acquiring 200ms
exposures every 2 seconds for several minutes. A. Histogram of capsid
transport velocities where the x-axis represents velocity in micrometers
per second (mm/sec) and the y-axis represents the number of TC-core
puncta. The solid curve represents the Gaussian best-fit curve, and the
dashed lines indicate the 95% confidence interval. Goodness of fit,
R
2=0.9883. B. Histogram of individual capsid run lengths where the x-
axis represents distance traveled in micrometers (mm) ad the y-axis
represents the number of TC-core puncta. The solid curve represents
the best-fit decaying exponential, and the dashed lines indicate the
95% confidence interval. Goodness of fit, R
2=0.9924.
doi:10.1371/journal.ppat.1002466.g006
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and cellular pathways involved in HCV egress. The data from the
RNAi screen delineates an egress pathway for HCV that heavily
interplays with the constitutive secretory pathway, which is
suggested for other viruses in the Flaviviridae (reviewed in [75]). If
we align the cellular cofactors of HCV egress along the constitutive
secretory pathway and also supplement with data from the
literature, the following molecular model of infectious HCV
secretion in Huh-7.5 cells is attained. HCV is hypothesized to
initiate assembly in close association with lipid droplets by coating
lipid droplets with the core protein and bringing together
nonstructural and structural proteins in a NS2-dependent manner
[23,51,76]. Following capsid assembly, nascent virions bud into
the lumen of the ER where the glycoproteins E1/E2 reside in
addition to the VLDL secretion machinery. HCV is infectious
upon envelopment at the ER, and it is thought that ApoE is
acquired early during assembly because knockdown of ApoE
reduces intracellular and extracellular virus [32]; also NS5A
interacts with ApoE [59,63]. We found through live cell imaging
TC-core cotransports extensively with ApoE-GFP (Figure 9A). In
addition, ApoE localizes to large, static, crescent shaped
accumulations of core presumably associated with lipid droplets
(Figure S12). Our data does not clearly distinguish whether HCV
hijacks the intact VLDL secretion pathway or associates with
ApoE through the NS5A interaction; however, the absence of
ApoB colocalization with TC-core puncta is more supportive of
the latter model (Figure S6).
The maturation of HCV particles overlaps with other aspects of
VLDL secretion. Nascent VLDL particles undergo further
lipidation and maturation in the Golgi [77,78] followed by ER
to Golgi trafficking dependent on SAR1A [67]. Our RNAi screen
implicated SAR1A in the production of extracellular HCV
suggesting HCV particles transport from the ER to the Golgi
with COPII secretory vesicles. The Golgi is further associated with
HCV secretion by the genes CYTH3, ARF3, AP1M1, PI4KB,
and PRKD1. During secretion, ARF GTPases such as CYTH3
Figure 7. Movement of TC-core is microtubule dependent. Huh-7.5 cells were electroporated with TC-core HCV RNA and at 72 hpe stained
with ReAsH (red) followed by incubation with 200 nM TubulinTracker Green. Images were acquired by taking alternating 200 ms DsRed and 200 ms
GFP exposures every 2 seconds. A. Top: Montage of TC-core (red) transport along microtubule (green). Elapsed time is 1 minute and the length of
single frame is 9.76 mm. Below: TC-core infected cells stained with ReAsH and TubulinTracker Green and then treated with 8 ug/mL nocodazole
immediately prior to imaging. Shown only is TC-core for simplicity, as there is low signal from the depolymerized microtubules. Elapsed time is
2 minutes 18 seconds. The length of the montage is 9.76 mm. B. Single particles from untreated, DMSO, or nocodazole treated cells were tracked and
the distance (y-axis) versus time (x-axis) was plotted. Distance plots were constructed using ImageJ Manual Tracking plugin, which provides the
instantaneous distance and velocity between two frames. Distance values were plotted versus time (x-axis). C. The average velocities of tracked
particles are shown. Error bars represent standard error of mean, asterisk indicates p-value ,0.0001.
doi:10.1371/journal.ppat.1002466.g007
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interact with coat proteins, such as AP1M1 to initiate vesicle
budding and sorting (reviewed in [79]). Treatment of HCV
infected cells with brefeldin A, which can inhibit ARF3, results in
the inhibition of infectious extracellular virus release [35]. We
visualized association of TC-core particles with TGN markers. In
contrast to a recent study [80], we did not find evidence of Golgi
disruption in either wild type HCV or TC-core (Figure 8) infected
cells and we found PRKD1 to be required for HCV release.
PI4KB (phosphatidylinositol kinase IIIb) appears to influence the
replication of some HCV genotype 1 isolates [81,82]. We observe
that in the case of J6/JFH1 infection, it plays a role in egress, and
not in entry or replication [44]. We cannot discount the possibility
that some of the siRNA treatments may affect secondary functions,
such as the post-translational modifications of viral proteins.
Following maturation of particles in the TGN, cargoes are
sorted into secretory vesicles en route to the plasma membrane.
Rab GTPases are master regulators of intracellular vesicle
trafficking, and we found that Rabs 11A and 3D were required
for efficient secretion of HCV. Rab11A positive recycling
endosomes sort some vesicles during exocytosis (reviewed in
[83]) to apical and basolateral membranes. We found TC-core
puncta colocalized with GFP-Rab11A and transferrin-488, a
marker for the recycling endosome, and some of these puncta
displayed directional transport (Figure 9B). The transient nature of
the interaction may be attributed to the recycling endosome
serving as a sorting station for membrane bound cargoes. Silencing
Rab11a leads to the increased accumulation of core in the Golgi,
further supporting a model wherein HCV virions bud from the
TGN and are transported to the recycling endosome.
VAMP1 and Rab11A were implicated in ours and other [84]
RNAi screens for host factors involved in HCV propagation.
VAMP1 is a v-snare that is loaded onto secretory vesicles at the
TGN and mediates the fusion of the vesicle with the plasma
membrane by interacting with SNAP-25 and syntaxins [74]. We
found a dynamic sub-population of TC-core that transports long-
range distances with GFP-VAMP1. TC-core also cotransports
with dextran, which also indicates vesicle association. Interestingly,
HCV core has been shown to localize with early and late
endosomal markers during egress time points and the release of
extracellular virus depended on endosome motility [85]. We have
confirmed that a smaller sub-population of TC-core cotraffics with
Rab5a-GFP labeled early endosomes (data not shown), however,
the interpretation of this data is complicated by the core-rab5A
interactions observed during endocytosis [43]. Due to the design of
the screen (excluding genes involved in HCVpp entry or replicon
replication), it is possible that some genes with multiple roles in the
viral life cycle were overlooked.
Trafficking of secretory vesicles and TC-core both require intact
microtubules (Figure 7). This is also supported by the observation
that the release of infectious extracellular HCV is disrupted by
depolymerization of microtubules [55]. We also found genes
involved in actin dynamics (RHOA, GIT1, WAS) to play a role in
HCV secretion. It is not thought actin dynamics are responsible
for the long-range transport we recorded for the TC-core virus,
but actin may play a role in the biogenesis of transport vesicles
(reviewed in [86]) and fusion of secretory vesicles at the plasma
membrane.
The dynamics of TC-core movements are consistent with
vesicular trafficking in the Huh-7.5 cells (Figure S13). HCV
particles, especially as lipo-viroparticles, are too large to freely
diffuse through the cytoplasm; instead they likely rely on
microtubules for long-range transport. Secreted HCV particles
may have several associated microtubule motors because TC-core
puncta display bidirectional transport. Because the majority of
TC-core puncta moving towards the plasma membrane (plus-end
transport) displayed a velocity curve that could be modeled by a
Gaussian distribution, a single class of plus ended motors is most
likely involved. Association of a minus-end motor is likely since
particles displayed bidirectionality, but we cannot rule out mixed
microtubule polarity in our Huh-7.5 cells.
Transport rates for TC-core puncta are below what has been
published for other viruses. Neurotropic herpesviruses display
transport kinetics consistent with fast axonal transport (2 mm/sec),
which does not occur in hepatocytes, and vaccinia virus displays
slower saltatory movements (1-3 mm/sec) (reviewed in [87]). In our
Figure 8. Localization of TC-core and markers of the TGN. A. Huh-7.5 cells were electroporated with TC-core RNA and at 72 hours post
infection cells were stained with ReAsH dye. Top panel: Cells were transduced with Golgi-GFP at 48 hours post electroporation then stained with
ReAsH. Bottom panels: Cells were stained with ReAsH dye at 72 hours post electroporation and processed for immunofluorescence using an antibody
directed against GM130. Arrows point to TC-core puncta colocalized with TGN markers. Scale bar is 10 mm. B. TC-core electroporated cells were
incubated with DMSO, PIK93 (0.5 mM), or brefeldin A (BFA) (1 mg/ml) for 2 hours prior to ReAsh staining. Drugs were present in staining and imaging
medias. Live cell imaging was performed and TC-core puncta were tracked. The average velocities were measured and are plotted. PIK93 or BFA
treatment significantly reduced average velocity (unpaired Student’s t-test).
doi:10.1371/journal.ppat.1002466.g008
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ApoE-associated vesicles in Huh-7.5 cells (Figure S13). Long-range
transport to the plasma membrane represented a net plus-end
movement that is comprised of small steps along the microtubule.
The slow rates of TC-core movement that we recorded can be
better resolved with higher spatial and temporal resolutions, as we
were only imaging rates of 1 frame per 2 seconds.
Previous characterization of HCV JC1 infection found less
core localization at lipid droplets and more ER localization than
is observed in HCV JFH1 infection [88]. This was interpreted as
possibly reflecting differences in the sites of assembly for HCV
JC1 and JFH1. In our experiments, the TC-core from JC1
clearly localizes at lipid droplets, in addition to the ER, Golgi,
and other secretory components. The predominant subcellular
Figure 9. TC-core HCV co-transports with host secretory pathway components. Huh-7.5 cells were electroporated with TC-core RNA
followed by transfection at 48 hours post electroporation with either ApoE-GFP (A), GFP-Rab11A (B), or GFP-VAMP1 (D) then ReAsH (red) stained at
72hpe. Otherwise, cells were incubated with transferrin-488 (C) or dextran (E) prior to imaging by confocal microscopy at 72 hours post
electroporation. Shown are montages of alternating DsRed (200ms) and EGFP (200ms) exposures taken every 2 seconds. Kymographs (distance on x-
axis and time on y-axis) of TC-core and cellular markers are shown to the right of the montage. Straight line on the y-axis indicates stalled transport
(time change only), whereas a diagonal line indicates transport (change in time and distance). Distance traveled and time elapsed (seconds) during
video acquisition are indicated on the kymograph. Arrows indicate the part of the kymograph shown in montages (left). See supplemental section for
videos. F. Quantification of TC-core puncta cotransport with cellular markers as a percentage of total TC-core puncta movers.
doi:10.1371/journal.ppat.1002466.g009
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not necessarily indicate a site of virion assembly, it simply
reflects which stage in core trafficking is rate limiting. For
instance, a slightly different interpretation is that JFH1
assembles virus at a lower efficiency than JC1, therefore more
core is at the lipid droplet awaiting completion of virion
assembly. Since JC1 virion assembly is more efficient than
JFH1, more core is localized to other subcellular compartments
involved in core trafficking, such as the ER. In support of this
interpretation, our TC-core virus has a higher amount of lipid
Figure 10. siRNA treatments inhibiting infectious virus production alter core sub-cellular localization. A. Huh7.5 cells were
electroporated with irrelevant (siIRR) or Rab11a (siRab11a) siRNAs followed by infection with HCV at 48 hours post electroporation. Cells were fixed
and stained with Golgi marker GM130 (green) and core (red) at 72 hours post infection. Immunofluorescence of siIRR (top) and siRab11a (bottom)
treated cells expressing viral core. White line in merge image is profiled for fluorescence intensity. RBG profile where distance is in pixels and
fluorescence intensity is in arbitrary fluorescence units (AU). Scale bar is 10 mm. B. Huh-7.5 cells electroporated with irrelevant (siIRR) or Pik4B (siPIK4B)
siRNAs, then infected with HCV at 48hpe followed by transfection with GFP-Vamp1 (green) at 72hpe. Cells were maintained for one day, then fixation
and stained with anti-core antibody (red). Top: siIRR treatment. Bottom. si-PI4KB treatment. RBG profile where distance is in pixels and fluorescence
intensity is in arbitrary fluorescence units (AU). Scale bar is 10 mm. C. Quantitation of core-GM130 colocalization in (A). Asterisk indicates p-value ,.01.
D. Quantitation of core Vamp1-GFP colocalization in (B). Asterisk indicates p-value ,.0001.
doi:10.1371/journal.ppat.1002466.g010
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efficient virion assembly.
We plan to revisit the trafficking studies in a more relevant
polarized hepatocyte cell culture system. Hepatocytes in vivo
possess complex architecture that consists of distinct basolateral
(sinusoidal) and apical (canalicular) plasma membrane domains,
which are separated by tight junctions. The association of apical
membranes from neighboring cells forms bile caniculi. With
complex polarity, also comes complex trafficking of proteins to
apical and basolateral membranes. Two pathways are used to
direct proteins to the apical membrane in hepatocytes, a direct
route or through transcytosis after reaching the basolateral
membrane. HCV is known to spread via two distinct routes,
extra-cellular release and cell-cell spread [89,90]. Future studies
will characterize the cell-cell spread trafficking pathway and
examine whether HCV undergoes selective polarized trafficking to
ultimately spread through an extracellular (basolateral) or
intracellular (apical) intermediate.
Materials and Methods
Virus and cells
Huh-7.5 cells were grown in Dulbecco’s modified high glucose
media (DMEM; Invitrogen) supplemented with 10% fetal bovine
serum (FBS; Invitrogen), nonessential amino acids (NEAA,
0.1 mM; Gibco), and 1% penicillin-streptomycin (Invitrogen).
Viral RNA was electroporated into Huh-7.5 cells as described
previously [43,44]. Viral supernatants were collected daily from up
to 5 passages of electroporated cells, filtered through a .22 mm
nitrocellulose filter, and kept at 4uC protected from light.
Plasmid constructs
pJFHxJ6-CNS2C3 (WT) is a HCV genotype 2a infectious clone
where core through the first transmembrane domain of NS2 of a
JFH-1backbonewasreplacedwith J6genotypesequence[91].Afull
length (FLNCCPGCCMEP) tetracysteine (TC) tag [92] was
inserted into the HCV core gene after amino acid 3 by amplifying
two regions (59 and 39 of the tag) and joining the two regions with an
ApaLI restriction site proximal to the tag insertion site. The full
length TC tag has been shown to enhance binding of biarsenical
dyes [92]. The 59 region was amplified using 59 AACGAATTC-
TAATACGACTCACTATAGACC and 59 AACGTGCACGG-
TCTACGAGACCTCCCGGGG (EcoRIa n dApaLI sites under-
lined). The 39 region was amplified using 59 AACGTGCAC
CATGAGCACATTTCTCAATTGTTGTCCTGGCTGTTG-
TATGGAACCTAATCCTAAACCTCAAAGAAAAACC and 59
AACCGTACG CCAAGATCATGGTAGCCGTGG (ApaLIa n d
BsiWI sites underlined, TC tag bolded). The 59 and 39 regions were
digested with ApaLI and ligated together to form the full-length core
region with the tag inserted. The TC-core fragment was
subsequently cloned into JFHxJ6NS23 using the EcoRIa n dBsiWI
sites and the TC tag insertion was confirmed by sequencing. The
bicistronic construct was constructed by insertion of a HCV
genotype 2a IRES – NS2 fragment into a subgenomic replicon,
pSGR-JFH1-neo, containing the encephalomyocarditis virus
(EMCV) IRES through the HCV replicase genes NS3-NS5B [52].
The IRES-NS2 fragment was PCR amplified by using the primers
59ACCGAATTCTAATACGACTCACTATAGACCTGCCCC-
TAATAG and 59 ACCGTTTAAACTTAAAGGAGCTTC-
CACCCCTTGGAGGTGTAGCCATCAGCTGG (EcoRIa n d
PmeI sites are underlined). The subsequent fragment was subcloned
in the replicon resulting in the bicistronic construct. The NS2
deletion construct was made by two-part subclone. NS2 was deleted
by insertion of the HCV genotype 2a IRES-p7 genes into a
subgenomic replicon as stated above. The IRES-p7 region was PCR
amplified by using the same EcoRI primer as above and 59
ACCGTTTAAACTTAAGCATAAGCCTGTTGGGGCAATG-
CTAGGAGCAGTAGGCTA (PmeI site underlined) which goes
through p7. The resulting PCR fragment was cloned in the
subgenomic replicon stated above. This resulted in the NS2 deletion
virus in a bicistronic backbone. The TC-tagged core was introduced
by digestion of the TC-core virus with EcoRIa n dBsiWIt ol i b e r a t ea
DNA fragment containing TC-core through part of glycoprotein
E1. Untagged core in the NS2 deletion backbone was replaced with
the TC-core fragment using the corresponding EcoRIa n dBsiWI
restriction sites. This resulted in a TC-core NS2 deletion (DNS2)
construct. The resulting clone was sequenced to verify in frame
insertion of the tag and presence of the deletion.
Apolipoprotein E was PCR amplified from a human ORF clone,
accession number EL733202 (Open Biosystems), using the primers
59 ACGAATTCATGAAGGTTCTGTGGGCTGC (EcoRIs i t ei s
underlined) and 59 GTGGATCCCGTGATTGTCGCTGGG-
CAC (BamHI site is underlined, bold indicates a 1nt insertion).
The PCR product was cloned into pEGFP-N2 at the EcoRIa n d
BamHI sites to create ApoE-GFP, and then confirmed by
sequencing. Rab11A was PCR amplified from a human ORF
clone, accession number CV027643 (Open Biosystems), using the
primers 59 ACCAAGCTTCGATGGGCACCCGCGACGAC-
GAGTACGAC (HindIII site is underlined) and 59 ACCGG
TACCTTAGATGTTCTGACAGCACTGCACCTT (KpnI site is
underlined). The PCR product was cloned into pmGFP-C1,
resulting in GFP-Rab11A and confirmed by sequencing. VAMP1
ORF was PCR amplified from a human ORF clone, accession
number CV029376 (Open Biosystems), using the primers 59
GCAGATCT ATGTCTGCTCCAGCTCAGCCACC (BglII site
is underlined) and 59 GCAAGCTT TCAGCGATACTTACTTA-
CAATAAC (HindIII site is underlined). The resulting PCR product
was cloned intopEGFP-C1 using the BglII and HindIII sites to result
in GFP-VAMP1 and confirmed by sequencing.
Viral replication curve and TCID50/mL
WT, TC-core, bicistronic, and DNS2 RNAs were transcribed in
vitro as described [52]. Huh-7.5 cells were electroporated with
2 mg/ml of each viral RNA and plated into 96 well plates. Viral
supernatants were collected at indicated times post electroporation
and titered by limiting dilution and immunohistochemical staining
using an antibody directed to NS5A (9E10) as described [1,93].
For intracellular infectious virus, the cells went through three
freeze-thaw cycles prior to titering. For RNA quantitation, cells
were washed twice with PBS and lysed in RLT lysis buffer
(Qiagen) at indicated timepoints. RNA was isolated using the
RNAeasy kit (Qiagen). RNA copy number was determined by
reverse transcriptase (RT) PCR analysis as described previously
[43,44] using the Platinum qRT-PCR Thermoscript One-Step
System (Applied Biosystems). 2 mL of extracted RNA was detected
using the following primers and probe: forward 59 ACTTCAT-
TAGCGGCATCCAATAC; reverse 59-CGGCACTGAATGC-
CATCAT; probe 59-6FAM-CAGGATTGTCAACACTGC-
CAGGGAACC - (Iowa Black), amplifies from the NS4 gene.
PCR conditions were 50uC for 30 minutes, 95uC for 6 minutes,
and (95uC for 15 seconds followed by 60uC for 1 minute) x 50
cycles.
RNA interference assay
The siRNAs used are listed in Table S1. The methods for the
primary RNAi screen have been previously described [43,44].
Briefly, the primary screen included pools of four siRNAs that
target 140 membrane trafficking genes (Dharmacon, Inc.). Genes
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silenced with four individual siRNAs targeting the gene to validate
the RNAi results. 1610
6 Huh-7.5 cells in 0.05 ml of PBS pH 7.4
were electroporated with 125 picomoles of siRNA for 5 pulses of
770 volts for 99 microseconds with one- second intervals on a
BTX 830 electroporator with 96-well attachment. Cells were
infected 72 hours after electroporation with a multiplicity of 0.5
infectious HCV particles per cell for 6 hours, rinsed with media,
then maintained for 2 days at 37uC. 48 hours after infection, the
supernatants were collected and analyzed for infectious virus via
limiting titer dilution as described previously [93]. Host gene
expression knockdown was assessed using the primer – probe sets
listed in Table S2.
For visualization of core localization during silencing, cells were
silenced with siRNAs followed by infection and immunofluores-
cence. Briefly, Huh-7.5 cells were electroporated (as above) with 2
pre-validated RAB11a siRNAs (Ambion, ID: s16073 and 14940),
2 pre-validated PIK4B siRNAs (Ambion, ID: 283 and s10543), or
irrelevant siRNA and silencing was established for 48 hours.
Electroporated cells were infected with HCV then maintained for
2 days, followed by seeding onto coverslips, fixation, and
immunofluorescence staining.
Immunofluorescence
HCV TC-core infected cells stained with biarsenical dye were
fixed in 4% paraformaldehyde for 10 min, permeabilized in 0.2%
Triton X-100 in PBS for 20 minutes, and blocked with 0.1%
Tween-20 and 10% goat serum in PBS for 30 min. Cell were
washed with PBS plus 0.1% Tween-20 (PBST) after blocking and
between antibody incubations. Primary and secondary antibodies
were diluted in PBST. For detection of core, a mouse monoclonal
antibody (#1851 Virostat, Portland, ME) was used at a dilution of
1:50, mouse monoclonal antibody to NS5A (9E10) was used at a
dilution of 1:1000, dsRNA antibody (J2, English and Scientific
Consulting Bt) was used at 1:1000, and a human monoclonal
antibody to E2 (Steve Foung) was used at 1:250. GFP fusion
proteins were assessed for correct localization by incubation with
antibodies. Anti-Apolipoprotein E (Abcam) was used at a dilution
of 1:250, anti-Vamp1 (Abcam) was used at a dilution of 1:250,
anti-Rab11a (Invitrogen) was used at a dilution of 1:250, anti-
GM130 (Abcam) was used at 1:250 to label the Golgi network, and
anti-ApoB was used at a dilution of 1:250. Alexa-488 or Alexa-594
conjugated IgG (Molecular Probes, Eugene, OR) secondary
antibodies were diluted 1:1000. Golgi-GFP (Invitrogen) was used
to label the TGN by the recommended directions. Bodipy 493/
503 was used to label neutral lipids (lipid droplets) in both fixed
and live cell images at a concentration of 20 mg/ml.
Biarsenical dye labeling of HCV expressing cells
FlAsH or ReAsH labeling was performed per the instructions
provided in the TC-tag detection kit (Invitrogen). At 72 hours post
electroporation, cells were washed once with Opti-MEM (Invitro-
gen) and labeled with biarsenical dye (1.25 mM) in Opti-MEM.
Cells were incubated at 37uC for 30 minutes, then washed two
times with 1X BAL (2,3-dimercapto-1-propanol) wash buffer
(supplied in the kit, Invitrogen) supplemented with 500 mM EDT
in Opti-MEM for 5 minutes. The wash buffer was removed and
the cells were washed one time using Opti-MEM followed by
incubation with prewarmed media.
Tracking of TC-core in the presence of drug inhibitors of the
secretory pathway was performed as follows: TC-core electropo-
rated cells were incubated with DMSO, GolgiPlug containing
BFA (1 mg/mL, BD Biosciences), or PIK93 (0.5 mM, Tocris) for
2 hours prior to staining with ReAsh. DMSO or drug was present
during time of staining and in the imaging media.
RNA labeling
Infected cells were incubated with Click-iT RNA Alexa Fluor 488
Imaging Kit (Invitrogen) to visualize RNA. Briefly, infected cells
were seeded on round coverslips and incubated with Click-iT kit as
per manufacturer’s instructions in the presence of actinomycin D
(1 mg/ml). Cells were processed for immunofluoresence after Click-
iT labeling.
Fluorescence microscopy
All images were acquired with an Olympus DSU spinning disk
confocal microscope fitted with a 10061.45 N.A oil-immersion
objective. FlAsH labeled core was detected using the EGFP filter
set (ex: 480/25 and em: 525/40), whereas ReAsH labeled core was
visualized with the DsRed filter set (ex: 565/25 and em: 620/60)
coupled to a Hamamatsu back-thinned EM-CCD high speed/
sensitivity camera. Slidebook software was used for image
acquisition and processing (Intelligent Imaging Innovations, Inc,
Denver, CO).
Immunofluorescence imaging of TC-core with viral or host
markers was accomplished by acquiring sequential static images
with DsRed, EGFP, and 350 filter set sequential exposures.
Live cell imaging of TC tagged HCV was performed by growing
infected cells on polylysine treated 35 mm glass bottom Fluor-
odishes (World Precision Instruments). Cells were stained with
biarsenical dye as above except imaging media (DMEM-F12-
Invitrogen) supplemented with 10% fetal bovine serum, 0.1 mM
nonessential amino acids, 1% penicillin-streptomycin, and 25 mM
HEPES was added following the final wash. Imaging chambers
were sealed with parafilm before imaging. Cells were maintained on
a heated stage set at 37uC. Timelapse imaging of TC-core particles
and GFP labeled host proteins was taken by sequential imaging
every 2 seconds with 200 ms exposures for each channel, DsRed
and GFP respectively. In some cases cells were incubated with
transferrin-488 (5 mg/mL, Invitrogen) or phrododextran (10 mg/
mL, Invitrogen) prior to imaging as per manufacturer’s instructions.
Individual core puncta transport velocities and run lengths were
calculated by kymograph analysis. Briefly, the multiple kymograph
plugin for ImageJ was used to generate kymographs. Runs were
defined as uninterrupted diagonal lines and the distance traveled
(length) and the average velocity (slope) were measured. The
frequency of TC-core puncta movement was measured by
quantifying the number of TC-core puncta displaying a run length
greater than 1 mm as a percentage of total cellular TC-core puncta
signal using the analyze particles tool in ImageJ per imaging session.
Distance from origin plots were generated by using the Manual
Trackingplugin for Image J,measuring thedistance traveled (in any
direction) between frames for a respective TC-core puncta. Values
were added and plotted against time. Manual Tracking plugin was
also used to generate the distance versus time plots. Distance
between timepoints was plotted versus time.
Statistical analysis
Prism software was used to plot and determine p-values for
replication and TCID50/mL titer curves. The velocity and run
length plots were also done using Prism software where the data
was modeled to a Gaussian distribution or a decaying exponential.
Supporting Information
Figure S1 Cell viability following electroporation with
the indicated siRNAs. Viability of siRNA-treated cells was
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experiments (A) and (B) by a luminescence-based assay (Promega)
that measures intracellular ATP levels. SEM is shown.
(TIF)
Figure S2 Intra- and extra-cellular infectious virus
following siRNA treatment. Relative levels of intra-and
extra-cellular infectious virus levels from Table 1.
(TIF)
Figure S3 Biarsenical dyes do not affect virus release.
Huh-7.5 cells were infected with wildtype virus for 48 hours then
incubated with ReAsh dye for 30 minutes. ReAsh dye was removed
and cells were washed with 1x BAL buffer supplemented with
500 mM EDT. Cells were incubated in fresh media and supernatants
were collect at 2, 8, 24, 48 hours post ReAsh incubation and titered.
(TIF)
Figure S4 Immunofluorescence of GFP fusions of ApoE,
Vamp1, and Rab11a. Huh7.5 cells were transfected with
ApoE-GFP, GFP-Vamp1, or GFP-Rab11a. Cells were fixed and
processed for immunofluorescence using antibodies directed
against ApoE (top), Rab11a (middle), GM130 (middle bottom)
or Vamp1 (bottom) and corresponding secondary antibodies (red).
Scale bar is 10 mm.
(TIF)
Figure S5 TC-core cotransports with ApoE-GFP. Huh-7.5
cells were electroporated with TC-core RNA and transfected with
ApoE-GFP at 48 hpe. Cells were stained with ReAsh (red) at 72
hpe then imaged. Boxed region contains TC-core puncta shown in
montage in Figure 9A and as a Video S7. Line indicates trajectory
of moving particle. Scale bar = 10 mm.
(TIF)
Figure S6 ApoB does not colocalize with TC-core
puncta. Huh7.5 cells were infected with TC-core virus and
stained with ReAsh dye (red) at 72 hours post infection followed
by processing for immunofluorescence using an ApoB antibody
(green). Scale bar is 10 mm.
(TIF)
Figure S7 TC-core cotransports with GFP-Rab11a. Huh-
7.5 cells were electroporated with TC-core RNA and transfected
with GFP-Rab11a at 48 hpe. Cells were stained with ReAsh (red)
at 72 hpe then imaged. Boxed region contains TC-core puncta
shown in montage in Figure 9B and as a Video S8. Line indicates
trajectory of moving particle. Scale bar = 10 mm.
(TIF)
Figure S8 TC-core cotransports with Alexa Fluor 488
transferrin. Huh-7.5 cells were electroporated with TC-core
RNA and stained with ReAsh (red) at 72 hpe then incubated with
Alexa Fluor 488 transferrin (green). Cells were immediately
imaged. Boxed region contains TC-core puncta shown in montage
in Figure 9C and as a Video S9. Line indicates trajectory of
moving particle. Scale bar = 10 mm.
(TIF)
Figure S9 TC-core cotransports with GFP-VAMP1. Huh-
7.5 cells were electroporated with TC-core RNA and transfected
with GFP-VAMP1 at 48 hpe. Cells were stained with ReAsh (red)
at 72 hpe then imaged. Boxed region contains TC-core puncta
shown in montage in Figure 9D and as a Video S10. Line indicates
trajectory of moving particle. Scale bar = 10 mm.
(TIF)
Figure S10 TC-core cotransports with dextran. Huh-7.5
cells were electroporated with TC-core RNA and stained with
FlAsh (green) at 72 hpe then incubated with dextran (red). Cells
were immediately imaged. Boxed region contains TC-core puncta
shown in montage in Figure 9E and as a Video S11. Line indicates
trajectory of moving particle. Scale bar = 10 mm.
(TIF)
Figure S11 TC-core produced in infected cells co-
transports with host secretory pathway components.
Huh-7.5 cells were infected with TC-core virus followed by
transfection with either ApoE-GFP (A), GFP-Rab11a (B), or GFP-
Vamp1 (C) plasmids at 24 hours post infection (hpi). Cells were
incubated with ReAsh at 72hpi followed by live cell confocal
microscopy. Shown are time-lapse montages of alternating DsRed
(200ms) and EGFP (200ms) exposures taken every 2 seconds for
several minutes. Kymographs are shown to the right of each montage.
(TIF)
Figure S12 ApoE-TC-core colocalization at core accu-
mulations. Huh-7.5 cells were electroporated with TC-core
RNA and transfected with ApoE-GFP at 48 hours post electro-
poration. Shown is ApoE (green) and TC-core (red) colocalization
at a crescent shaped core accumulation (inset), presumably at a
lipid droplet. Scale bar 10 mm.
(TIF)
Figure S13 Vamp-1 and ApoE vesicle dynamics. Huh-7.5
cells were transfected with ApoE-GFP or GFP-VAMP1 constructs.
200ms GFP exposures were taken by confocal microscopy every 2
seconds. Single GFP puncta were tracked using the manual
tracking plugin for Image J. Plotted are average (A) velocity (mm/
sec) and (B) run length (mm). Overall, 16 VAMP1-GFP vesicles (59
total runs) and 15 ApoE-GFP vesicles (90 total runs) were tracked.
Error bars indicate standard error of the mean.
(TIF)
Table S1 Genes and siRNAs tested in the RNA interfer-
ence screen.
(DOC)
Table S2 Real time RT-PCR assays for quantifying host
gene RNA levels.
(DOC)
Video S1 Dynamics of TC-core puncta. Snapshot of this
Video is shown in Figure 2C. Playback time is 10x real speed.
(AVI)
Video S2 TC-core dynamics. Montage of single TC-core
puncta transport shown in Figure 4A. Playback time is 10x real
speed.
(AVI)
Video S3 TC-core dynamics in bicistronic background.
Montage of single TC-core puncta transport shown in Figure 4A.
Playback time is 10x real speed.
(AVI)
Video S4 TC-core dynamics in DNS2 background.
Montage of single TC-core puncta transport shown in Figure 4A.
Playback time is 10x real speed.
(AVI)
Video S5 TC-core dynamics and microtubules stained
with Tubulin Tracker green. Shown as montage in Figure 7A.
Playback time is 10x real speed.
(AVI)
Video S6 TC-core dynamics in the presence of nocoda-
zole. Shown as a montage in Figure 7B.
(AVI)
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montage in Figure 9A. Snapshot of whole cell shown in Figure S2.
(AVI)
Video S8 TC-core traffics with GFP-Rab11a. Shown as a
montage in Figure 9B. Snapshot of whole cell shown in Figure S3.
(AVI)
Video S9 TC-core traffics with Alexa Fluor 488 trans-
ferrin. Shown as a montage in Figure 9C. Snapshot of whole cell
shown in Figure S4.
(AVI)
Video S10 TC-core traffics with GFP-VAMP1. Shown as a
montage in Figure 9D. Snapshot of whole cell shown in Figure S5.
(AVI)
Video S11 TC-core traffics with dextran. Shown as a
montage in Figure 9E. Snapshot of whole cell shown in Figure S6.
(AVI)
Video S12 TC-core traffics with Ribogreen labeled
RNA. Shown as montage in Figure 2D.
(MOV)
Video S13 TC-core in infected cells traffics with ApoE-
GFP. Shown as a montage in S11.
(AVI)
Video S14 TC-core in infected cells traffics with GFP-
Rab11a. Shown as a montage in S11.
(MOV)
Video S15 TC-core in infected cells traffics with GFP-
Vamp1. Shown as a montage in S11.
(MOV)
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